2QB0.F OCUMETICS TECHNOLOGY CORP

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
0.2200 EUR
Close of Nov 11, 2026
0.1950 0.5750
Market cap
EUR 28.6M
P/E
-
P/B
50.01x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Apr 2026.

Is 2QB0.F undervalued?

Graham number

The Graham number of OCUMETICS TECHNOLOGY CORP cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

OCUMETICS TECHNOLOGY CORP fundamental analysis

No fundamental analysis for OCUMETICS TECHNOLOGY CORP yet.

OCUMETICS TECHNOLOGY CORP stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About OCUMETICS TECHNOLOGY CORP

Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. It develops expandable intraocular lenses to eliminate the need for corrective lenses primarily for people over 45 years of age. The company was formerly known as Quantum Blockchain Technologies Ltd. and changed its name to Ocumetics Technology Corp. in August 2021. The company was founded in 2012 and is headquartered in Calgary, Canada.

Full company profile